Previous 10 | Next 10 |
2023-10-13 07:43:40 ET More on Orion Group Orion: Prolonged Execution Issues, Turnaround Strategy Lacks Clarity Orion Group Holdings, Inc. (ORN) Q2 2023 Earnings Call Transcript Orion Group jumps to 17-month high after B. Riley upgrade to Buy Seeking Alpha...
HOUSTON, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion” and “Company”), a leading specialty construction and engineering company today announced a significant contract award valued at over $100 million for its Marine and Engineering b...
2023-10-11 08:49:26 ET Summary Operating losses in majority of past 10 years indicate a flawed strategy or poor execution. Balance sheet concerns are not fully addressed by recent debt refinancing. Valuation is not cheap enough to compensate for an above-average risk profile. ...
At the 36th European College of Neuropsychopharmacology congress (ECNP-2023) MADRID, Spain and BOSTON, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseas...
HOUSTON, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion” and “Company”), a leading specialty construction and engineering company today announced it received the Company Award for Leadership in Safety from the Council of Dredging and M...
HOUSTON, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (the "Company"), a leading specialty construction company, today announced that it will issue its financial results for the third quarter ended September 30, 2023, on Wednesday, October 25, 2023, after the close of ...
Orion Group Holdings, Inc. (NYSE: ORN) is the focus of IBN's latest stock spotlight. The company's shares have moved -3.29% on the day to $4.93. Orion Group Holdings, Inc. operates as a specialty construction company in the building, industrial, and infrastructure sectors in the continental Un...
Two collaborative projects with public research centers with a global budget of 2.3 million euros Oryzon to receive up to 1.4 million euros Focused on the discovery and validation of novel biomarkers and epigenetic targets for the treatment of neuronal pathologies MADR...
East-West Biopharma Summit 36th European College of Neuropsychopharmacology congress (ECNP 2023) Investor Access 2023 Event Jefferies Inaugural Biotech CNS/Neuro Summit Roth Capital Partners 2 nd Healthcare Opportunities Conference ESMO (Eur...
Orion Group Holdings, Inc. (NYSE: ORN) is the focus of IBN's latest stock spotlight. The company's shares have moved -1.92% on the day to $5.11. Orion Group Holdings, Inc. operates as a specialty construction company in the building, industrial, and infrastructure sectors in the continental Un...
News, Short Squeeze, Breakout and More Instantly...
Orion Group Holdings Inc. Common Company Name:
ORN Stock Symbol:
NYSE Market:
Orion Group Holdings Inc. Common Website:
MADRID and CAMBRIDGE, Mass., July 08, 2024 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received “Deci...
HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN) (“Orion”, "Company"), a leading specialty construction company, today announced that it will issue its second quarter 2024 financial results after the close of the stock market on Wednesday, July 24, 2...
2024-07-06 15:46:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...